A Single Dose Study of LY3023703 in Healthy Participants

NCT01632579 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: LY3023703
DRUG: Placebo
DRUG: Celecoxib

Sponsor

Eli Lilly and Company